Skip to content
    CTVA
    Earnings call· Jun 2025(Q2 FY25)

    Corteva Q2 FY25 earnings call CTVA

    Aug 7, 2025 Source

    Executive summary

    Corteva Q2 FY25 — Strong H1 Performance Drives Raised Full-Year Outlook

    Corteva delivered strong top and bottom-line growth in Q2 and H1 FY25, driven by robust demand for proprietary technology, operational excellence, and significant cost improvements. The company raised its full-year operating EBITDA, EPS, and free cash flow guidance, reflecting confidence in continued execution and strategic initiatives like royalty neutrality and productivity gains, despite anticipated pricing pressures in Crop Protection and currency headwinds.

    Highlights

    5

    • Operating EBITDA margin expanded by over 200 basis points in Q2 and 300 basis points in H1.

    • Exceeded 2025 net cost improvement target in H1, raising full-year target to $450 million from $400 million.

    • Seed business delivered 280 basis points of operating EBITDA margin expansion and pricing gains in most regions in H1.

    • Achieved $70 million benefit in net royalties in H1, exceeding full-year expectation of $65 million.

    • Raised full-year operating EBITDA guidance midpoint to $3.8 billion, a $100 million improvement.

    Concerns

    4

    • Crop Protection expects low to mid-single-digit pricing headwinds in H2.

    • Currency headwinds of approximately $150 million on EBITDA in H1, driven by Turkish Lira and Canadian Dollar.

    • Anticipates a typical seasonal Q3 operating EBITDA loss at least as large as prior year.

    • Crop Protection H2 EBITDA expected to be down high single digits due to strong prior-year comparable.

    Guidance & targets

    14
    CategoryTargetConfidence
    Full-year Operating EBITDA
    $3.75 billion to $3.85 billion
    high materiality
    High
    Full-year Operating EBITDA Margin Expansion
    approximately 150 basis points
    medium materiality
    High
    Full-year Operating EPS
    $3 to $3.20 per share
    high materiality
    High
    Full-year Free Cash Flow
    approximately $1.9 billion
    medium materiality
    High
    Full-year Free Cash Flow Conversion Rate
    about 50%
    medium materiality
    High
    Full-year Share Repurchases
    $1 billion
    medium materiality
    High
    Annual Dividend Increase
    nearly 6%
    medium materiality
    High
    Combined Cash Returned to Shareholders
    roughly $1.5 billion
    medium materiality
    High
    Net Royalty Neutrality
    by 2028
    high materiality
    High
    2027 Financial Framework
    well within
    high materiality
    High
    Crop Protection H2 EBITDA
    down high single digits
    medium materiality
    Medium
    Overall H2 Growth
    mid-single-digit growth
    medium materiality
    Medium
    Q3 Operating EBITDA
    loss at least as large as what we saw last year
    low materiality
    High
    Full-year R&D as % of Sales
    8%
    low materiality
    High

    Segment performance

    2
    SegmentRevenueYoYQoQMargin
    Seed
    Seed delivered impressive performance in the first half, driven by strong North American results, market share gains, and significant royalty benefits. The business is seeing strong early order velocity for Latin American crops.
    H1 Operating EBITDA margin expansion: 280 basis pointsH1 Pricing gains: most regionsH1 Volume improvement: North AmericaH1 Net royalties benefit: $70 millionH1 Operating EBITDA growth: 11%H1 Price gains: 3%H1 Volume gains: 2%2026 Pricing: low single digits (corn and soy)Brazil summer crop orders in hand: 90%Brazil safrinha orders in hand: 40%Argentina acreage rebound: mid-single digitsBrazil summer/safrinha acres increase: mid-single digits
    		————
    Crop Protection
    Crop Protection achieved strong volume growth, particularly in Latin America and new products, benefiting from productivity and deflation. However, the segment continues to face competitive pricing pressures, especially in Brazil, impacting the second half outlook.
    H1 Operating EBITDA margin expansion: over 350 basis pointsQ2 Volume gains: double-digitH1 Volume gains: 8%H1 New products and biologicals volume gains: double-digitH1 Operating EBITDA growth: double-digitH1 Price: down 2%H2 Pricing: low to mid-single-digit declinesH2 EBITDA: down high single digitsDifferentiated portfolio: about 2/3 of totalDifferentiated portfolio gross margin uplift: 15% above overall average
    		————

    Operational metrics

    23
    Net cost improvement target
    $450 millionfrom $400 million
    FY25

    Exceeded 2025 target in H1 alone.

    Productivity and cost benefits
    more than $400 million
    H1 FY25

    Combined from Seed and Crop Protection, including lower seed commodity costs, raw material deflation, and productivity actions.

    SG&A
    upcompared to prior year
    H1 FY25

    Driven by higher commissions, compensation expense, and bad debt.

    R&D as % of sales
    8%
    FY25

    On track to reach target for the full year.

    Currency headwind on EBITDA
    roughly $150 million
    H1 FY25

    Driven by Turkish Lira and Canadian Dollar.

    Free cash flow conversion rate
    about 50%4% uplift
    FY25

    Improvement driven by earnings growth and lower cash taxes from recent legislation.

    Organic sales growth
    5%over last year
    H1 FY25

    Growth in both Seed and Crop Protection.

    Organic sales growth
    7%compared to prior year
    Q2 FY25

    Gains in both Seed and Crop Protection.

    Pricing
    up 1%
    Q2 FY25

    Gains in Seed partially offset by continued pressure in Crop Protection.

    Volumes
    up 6%
    Q2 FY25

    Seed gains in nearly every region and double-digit Crop Protection volume growth led by Latin America.

    Operating EBITDA growth
    13%
    Q2 FY25

    Driven by top line growth and meaningful cost improvement.

    Operating EBITDA margin expansion
    215 basis pointscompared to prior year
    Q2 FY25

    Driven by top line growth and meaningful cost improvement.

    Operating EBITDA growth
    14%over prior year
    H1 FY25

    Driven by organic sales growth, lower input costs, and productivity.

    Operating EBITDA margin
    nearly 31%up about 300 basis points
    H1 FY25

    Driven by organic sales growth, lower input costs, and productivity.

    Cost and productivity benefits
    moderate
    H2 FY25

    As company laps deflationary impacts from H2 2024 for Crop Protection.

    Currency headwind
    —
    H2 FY25

    Expected from Brazilian Real due to hedge impacts.

    Operating EBITDA split (H1/H2)
    aligned with historical average
    FY25

    Anticipates a typical seasonal earnings pattern.

    Differentiated portfolio gross margin uplift
    15%
    current

    Above overall average for the 2/3 differentiated portfolio in Crop Protection.

    Biologicals market share
    10%
    current

    Expected to grow significantly over the next decade.

    Haviza peak revenue
    $500 million
    peak

    Blockbuster molecule for soybean rust in Brazil.

    North America corn/soy acres
    180 million
    FY26

    Expected total planted acres for both crops.

    Brazil corn ethanol production
    20%
    current

    Of the country's total ethanol production.

    Seed out-licensing opportunity
    $4 billion
    long-term

    Primarily in North America and Latin America.

    Industry KPIs

    2
    MetricValueDetails
    Volume vs price splitVolume up 6%, Price up 1%%
    Productivity cost savings program$450 millionUSD

    Product announcements

    3
    ProductTypeDetails
    Forcivolaunch
    Havizalaunch
    Reklemelupdate

    Deals & partnerships

    1
    FMCPartnership for a new 3-way fungicide, Forcivo, for the North America corn market.

    Corteva will market Forcivo, a new 3-way fungicide, in North America corn, expanding its portfolio in this segment.

    Risks & headwinds

    5
    Competitive market dynamics leading to pricing pressure in Crop ProtectionH2 FY25

    low to mid-single-digit pricing headwinds in H2

    Mitigation: Operational excellence, cost reductions, focus on differentiated technology.

    Negative impact from currency fluctuationsH1 FY25 (Turkish Lira, Canadian Dollar), H2 FY25 (Brazilian Real)

    roughly $150 million headwind on EBITDA in H1

    Mitigation: Hedge impacts.

    Farmer economics and liquidity influencing prepaid depositsQ4 FY25

    Not quantified

    Mitigation: Monitoring closely.

    Moderated overall crop prices and thin farmer marginsCurrent

    Not quantified

    Mitigation: Farmers prioritizing top-tier seed and crop protection technologies to maximize yields.

    Trade uncertainty and geopolitics impacting trade routesNext year (2026 planting decisions)

    Not quantified

    Mitigation: Advocating for opening up global markets for trade.

    What to watch in Q3 FY25

    5

    Crop Protection Pricing Trend

    Next quarter / H1 FY26
    Currentlow to mid-single-digit declines expected in H2 FY25
    TargetStabilization or improvement in pricing

    Why it matters

    Pricing is a key constraint for CP business growth and overall profitability.

    On pricing, we anticipate low single-digit gains in Seed and low to mid-single-digit declines in Crop Protection.

    Q&A highlights

    7

    Analyst inquired about the key factors influencing the second half forecast, specifically tough Crop Protection comparables, negative pricing in Brazil, Seed acreage expectations, prepaid deposits, and FX impacts, and how these shape the range of outcomes.

    Management confirmed these factors are central to the H2 outlook. They highlighted the strong H2 2024 comparable for Crop Protection, ongoing pricing pressures in Brazil, and FX headwinds, particularly from the Brazilian Real. Seed acreage in Latin America is expected to see mid-single-digit increases, with strong early order books for Brazil's summer and safrinha crops.

    “Yes, pretty much, I think you summed it up pretty well. I mean when we look at the year-over-year in the back half -- and I'd just remind everyone that I know you know this, but our back half typically is only 12% or 13% of our entire EBITDA for the year.”

    asked by Vincent Andrews · answered by David Johnson

    2 min read7 chapters

    Detailed Narrative

    01

    First Half Performance Highlights

    Corteva delivered strong top and bottom-line growth in the second quarter and first half of 2025. Organic sales were up 7% in Q2 and 5% in H1, with both Seed and Crop Protection contributing. Operating EBITDA grew 13% in Q2 and 14% in H1, leading to significant margin expansion of 215 basis points in Q2 and 300 basis points in H1, driven by organic sales growth, lower input costs, and productivity.

    02

    Cost and Productivity Initiatives

    The company exceeded its 2025 net cost improvement target in the first half, leading to an increased full-year target of $450 million from $400 million. Seed and Crop Protection combined to deliver over $400 million in productivity and cost benefits in H1, stemming from lower seed commodity costs, raw material deflation, and ongoing productivity actions. These initiatives are a key lever for achieving the 2027 financial framework.

    03

    Seed Business Momentum

    Seed demonstrated impressive performance in H1, with 280 basis points of operating EBITDA margin expansion and pricing gains across most regions. Volume improvement in North America made a significant contribution, and the company believes it delivered healthy branded share gains in both corn and soybeans. Out-licensing results also exceeded expectations, providing a $70 million net royalty benefit in H1.

    04

    Crop Protection Dynamics

    The Crop Protection business saw double-digit volume growth in Q2 and 8% in H1, led by Latin America and strong performance in new products and biologicals. Despite these gains, the segment faced competitive market dynamics, resulting in a 2% price decline in H1 and an expected low to mid-single-digit decline in H2. However, management noted that the overall CP market is slowly improving with stabilized generic pricing.

    05

    Updated Full-Year Outlook

    Corteva raised its full-year operating EBITDA guidance midpoint to $3.8 billion, representing 13% growth. Operating EPS guidance was increased to $3 to $3.20 per share, up 21% at the midpoint. Free cash flow guidance was also raised to approximately $1.9 billion, with a cash conversion rate of about 50%, primarily due to earnings growth and lower cash taxes from recent legislation.

    06

    Capital Allocation Strategy

    The company remains on track for $1 billion in share repurchases in 2025 and announced a nearly 6% increase in its annual dividend, marking the fifth consecutive annual increase. Combined, these actions are expected to return approximately $1.5 billion in cash to shareholders during 2025, reflecting a strong balance sheet and cash flow outlook.

    07

    Market Fundamentals and 2026 Outlook

    Ag fundamentals are mixed, with growing demand for grains and oilseeds but moderated crop prices. Despite expectations for a record U.S. harvest, the stocks-to-use ratio for corn is expected to remain below historical averages. Management remains constructive on growth for 2026, anticipating it will keep the company well within its 2027 financial framework, with more details to be provided in Q3.

    AI-generated summary of the company’s earnings call. Not investment advice.